| dc.contributor.author | Baines, Simon D. | |
| dc.contributor.author | O'Connor, Rachael | |
| dc.contributor.author | Saxton, Katie | |
| dc.contributor.author | Freeman, Jane | |
| dc.contributor.author | Wilcox, Mark H. | |
| dc.date.accessioned | 2013-09-02T11:00:00Z | |
| dc.date.available | 2013-09-02T11:00:00Z | |
| dc.date.issued | 2008 | |
| dc.identifier.citation | Baines , S D , O'Connor , R , Saxton , K , Freeman , J & Wilcox , M H 2008 , ' Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model ' , Journal of Antimicrobial Chemotherapy , vol. 62 , no. 5 , pp. 1078-85 . https://doi.org/10.1093/jac/dkn358 | |
| dc.identifier.issn | 1460-2091 | |
| dc.identifier.uri | http://hdl.handle.net/2299/11458 | |
| dc.description.abstract | To compare the efficacy of oritavancin and vancomycin in the treatment of Clostridium difficile infection (CDI) using an in vitro human gut model. | en |
| dc.format.extent | 8 | |
| dc.format.extent | 298701 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Journal of Antimicrobial Chemotherapy | |
| dc.title | Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model | en |
| dc.contributor.institution | School of Life and Medical Sciences | |
| dc.contributor.institution | Microbiology and Biotechnology | |
| dc.contributor.institution | Biosciences Research Group | |
| dc.contributor.institution | Centre for Research in Mechanisms of Disease and Drug Discovery | |
| dc.contributor.institution | Department of Clinical, Pharmaceutical and Biological Science | |
| dc.contributor.institution | Centre for Future Societies Research | |
| dc.description.status | Peer reviewed | |
| rioxxterms.versionofrecord | 10.1093/jac/dkn358 | |
| rioxxterms.type | Journal Article/Review | |
| herts.preservation.rarelyaccessed | true | |
